Citations

Showing 10 of 108162 citations.

Antibacterial Resistance Leadership Group 2.0: Back to Business
Chambers, Henry F. , Patel, Robin , Cross, H. R. , Harris, Anthony , Doi, Yohei , Boucher, Helen W., Tsalik, Ephraim L. , Holland, Thomas L , Pettigrew, Melinda M. , Hodges, Kathryn R., Souli, Maria , Fowler, Vance G. , van Duin, David , Tamma, Pranita D , Patel, Robin , Doi, Yohei , Pettigrew, M M , Evans, Scott R , Evans, Scott , Cross, Heather R, Harris, Anthony D. , Tamma, Pranita D. , Fowler, Vance G. , Holland, Thomas L.

Mayo Clinic

Clinical Infectious Diseases | February 10, 2021 | Volume: 73 | Issue: 4 | Pages: 730-739

10.1093/cid/ciab141 | PMID 33588438 Get It

Abstract In December 2019, the Antibacterial Resistance Leadership Group (ARLG) was awarded funding for another 7-year cycle to support a clinical research network on antibacterial resistance. ARLG 2.0 has 3 overarching research priorities: infections caused by antibiotic-resistant (AR) gram-negative bacteria, infections caused by AR gram-positive bacteria, and diagnostic tests to optimize use of antibiotics. To support the next generation of AR researchers, the ARLG offers 3 mentoring opportunities: the ARLG Fellowship, Early Stage Investigator seed grants, and the Trialists in Training Program. The purpose of this article is to update the scientific community on the progress made in the original funding period and to encourage submission of clinical research that addresses 1 or more of the research priority areas of ARLG 2.0.
A Comparison of Human Chorionic Gonadotropin– Related Components in Fresh Frozen Serum With the Proficiency Testing Material Used by the College of American Pathologists
Knight, George J., Klee, George G., Schreiber, William E. , Cole, Lawrence A., Richards, C. Sue

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 10, 2021 | Volume: 129 | Issue: 3 | Pages: 328-330

10.5858/2005-129-328-acohcg | PMID 15737026 Get It

Abstract Context. —As part of a College of American Pathologists (CAP) proficiency testing survey, a comparison is made between human chorionic gonadotropin (hCG) results from an actual patient pool and a similarly targeted artificial sample. The goal is to gain insight into the possible source(s) of bias attributable to the proficiency testing material (PTM) with a view toward creating more appropriate survey materials. Objective. —To compare hCG and related variants in a pool of fresh frozen sera (FFS) with that found in PTM. Design. —The 2003 CAP K/KN-A Survey included a FFS specimen along with admixtures of PTM. The FFS (K-02) and 1 PTM admixture (K-01) had similar mean hCG values. Five hCG-related analytes were measured on these 2 samples by a reference laboratory. Participants. —Approximately 1800 clinical laboratories and diagnostic test kit manufacturers participated in the K/ KN-A Survey. Main Outcome Measures. —Method imprecision (coefficient of variation) and method bias (relative difference between peer group mean and all-method median) were computed for the 2 samples. Differences were evaluated with respect to hCG-related analytes levels. Results. —All-method hCG results were 12.9 mIU/mL (12.9 IU/L) for the PTM material and 21.6 mIU/mL (21.6 IU/L) for the FFS material. Method biases for 14 manufacturers were greater for PTM than for FFS (−40% to +35% and −16% to +23%). Twelve of 14 methods had higher coefficients of variation on PTM. Total hCG and free β hCG measurements by the reference laboratory were 14.1 mIU/ mL (14.1 IU/L) for the PTM material and 18.5 mIU/mL (18.5 U/L) for the FFS material (FFS), and 2.4 (PTM) and 0.7 (FFS) mIU/mL (2.4 and 0.7 IU/L), respectively. On a molar basis, free β represented 17% and 4% of the total hCG, respectively. Levels of hyperglycosylated hCG, nicked hCG, and β core fragment were not measurable in either sample. Conclusions. —It is unlikely that the hCG added to the PTM is the source of the increased bias and variability. The main difference is a 3-fold increase in free β found in the PTM, but methods previously found to strongly react with free β were not systematically elevated. The biases between manufacturers found for the FFS specimen are likely attributable to calibration differences.
Analytic Bias of Thyroid Function Tests: Analysis of a College of American Pathologists Fresh Frozen Serum Pool by 3900 Clinical Laboratories
Steele, Bernard W., Klee, George G., Thienpont, Linda M., Soldin, Steven J., Sokoll, Lori J. , Winter, William E. , Fuhrman, Susan, Elin, Ronald J., Wang, Edward

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 10, 2021 | Volume: 129 | Issue: 3 | Pages: 310-317

10.5858/2005-129-310-abotft | PMID 15737023 Get It

Abstract Context. —In proficiency testing surveys, there are differences in the values reported by users of various analytic methods. Two contributors to this variation are calibrator bias and matrix effects of proficiency testing materials. Objectives. —(1) To quantify the biases of the analytic methods used to measure thyroid-stimulating hormone, thyroxine, triiodothyronine, free thyroxine, and free triiodothyronine levels; (2) to determine if these biases are within allowable limits; and (3) to ascertain if proficiency testing materials correctly identify these biases. Design. —A fresh frozen serum specimen was mailed as part of the 2003 College of American Pathologists Ligand and Chemistry surveys. The means and SDs for each analytic method were determined for this sample as well as for a proficiency testing sample from both surveys. In the fresh frozen serum sample, target values for thyroxine and triiodothyronine were determined by isotope dilution/liquid chromatography/tandem mass spectrometry. All other target values in the study were the median of the means obtained for the various analytic methods. Main Outcome Measures. —Calibration biases were calculated by comparing the mean of each analytic method with the appropriate target values. These biases were evaluated against limits based on intra- and interindividual biological variation. Matrix effects of proficiency testing materials were assessed by comparing the rank of highest to lowest analytic method means (Spearman rank test) for each analyte. Participants. —Approximately 3900 clinical laboratories were enrolled in the College of American Pathologists Chemistry and Ligand surveys. Results. —The number of methods in the Ligand Survey that failed to meet the goals for bias was 7 of 17 for thyroid-stimulating hormone and 11 of 13 for free thyroxine. The failure rates were 12 of 16 methods for thyroxine, 8 of 11 for triiodothyronine, and 9 of 11 for free triiodothyronine. The means of the analytic method for the proficiency testing material correlated significantly ( P < .05) only with the fresh frozen serum means for thyroxine and thyroid-stimulating hormone in the Chemistry Survey and free triiodothyronine in the Ligand Survey. Conclusions. —A majority of the methods used in thyroid function testing have biases that limit their clinical utility. Traditional proficiency testing materials do not adequately reflect these biases.
Comparison of Pooled Fresh Frozen Serum to Proficiency Testing Material in College of American Pathologists Surveys: Cortisol and Immunoglobulin E
Palmer‐Toy, Darryl E. , Wang, Edward , Winter, William E. , Soldin, Steven J., Klee, George G., Howanitz, Joan H., Elin, Ronald J.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 10, 2021 | Volume: 129 | Issue: 3 | Pages: 305-309

10.5858/2005-129-305-copffs | PMID 15737022 Get It

Abstract Context. —The College of American Pathologists (CAP) provides proficiency testing (PT) surveys to laboratories around the world. Objectives. —To compare diagnostic assay methods for serum/plasma cortisol and immunoglobulin (Ig) E in terms of their bias and precision, to determine how well CAP PT specimens simulate human serum, and to reassess proficiency test grading criteria in light of these findings. Design. —A participant-blinded, prospective trial. One vial of pooled fresh frozen serum (FFS) and 4 different admixtures of PT material (PTM) were sent to laboratories participating in PT surveys. Participants. —Laboratories providing cortisol (>1000) or IgE (>230) results among the subscribers to the CAP surveys, Ligand (General) 2003, set K/KN-A and Chemistry 2003, set C-C. Main Outcome Measures. —The main outcome measures were (1) bias among laboratories using the same method (peer groups), defined relative to the median of method means (MedMM); (2) imprecision as measured by the SD and coefficient of variation (CV) about each method mean; and (3) total error across laboratories for the FFS cortisol results, defined as |Bias Relative to Reference Method| + 2 SD. Results. —Cortisol method biases, relative to MedMM, ranged from −22% to 9% for the FFS challenge and from −24% to 36% for comparable PTM challenges. The method biases, relative to the reference method, ranged from −3% to 19% for the FFS challenge. The cortisol method CVs ranged from 4.2% to 13.6% for the FFS challenge and from 4.7% to 12.7% for comparable PTM challenges. Total error across laboratories ranged from 1.4 to 6.9 μg/dL (39 to 190 nmol/L) for the FFS challenge. Immunoglobulin E method biases, relative to MedMM, ranged from −8% to 9% for the FFS challenge and from −7% to 5% for comparable PTM challenges. The IgE method CVs ranged from 3.6% to 6.7% for the FFS challenge and from 3.4% to 9.8% for comparable PTM challenges. Conclusions. —The bias for cortisol results was less with FFS than with PTM, but imprecision was comparable. The FFS MedMM was 8.5% higher than the reference value. Fresh frozen serum and PTM bias and imprecision for IgE methods were each less than 10%. Because some of the methods demonstrated greater bias when analyzing PTM than FFS, peer group grading of both these analytes is appropriate.
College of American Pathologists 2003 Fresh Frozen Serum Proficiency Testing Studies
Klee, George G., Killeen, Anthony A.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 10, 2021 | Volume: 129 | Issue: 3 | Pages: 292-293

10.5858/2005-129-292-coapff | PMID 15737018 Get It

Sinusoidal Dilatation and Congestion in Liver Biopsy: Is It Always Due to Venous Outflow Impairment?
Kakar, Sanjay , Kamath, Patrick S. , Burgart, Lawrence J., Kakar, Sanjay

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 10, 2021 | Volume: 128 | Issue: 8 | Pages: 901-904

10.5858/2004-128-901-sdacil | PMID 15270610 Get It

Abstract Context. —Impairment of venous outflow manifests as zone 3 sinusoidal dilatation and congestion (SDC) in liver biopsy. However, the finding of SDC is not specific for venous outflow impairment. Objectives. —To determine the specificity of SDC in liver biopsies for venous outflow impairment and to seek an explanation for SDC in patients without clinical or radiologic features of venous outflow impairment. Design. —Liver biopsies from 51 patients with sinusoidal dilatation were reviewed. Biopsies from transplant recipients, patients with cirrhosis, and patients with hepatic neoplasms (primary or metastatic) were not included. Clinical records were reviewed for laboratory tests and final clinicopathologic diagnosis. Results. —Thirty-four patients (66.7%) had confirmed venous outflow impairment. Of the 17 cases (33.3%) without clinical and/or radiologic evidence of venous outflow impairment, vascular causes were present in 5 cases (9.8%; nodular regenerative hyperplasia in 2 cases and portal vein thrombosis, congenital absence of the portal vein, and sickle cell anemia in 1 case each). Systemic inflammatory disorders were identified in 6 patients (11.8%). These included 2 cases of Castleman disease and 1 each of sarcoidosis, Crohn disease, rheumatoid arthritis, and Still disease. Three patients (5.9%) had tumors without direct involvement of the liver (1 case each of Hodgkin lymphoma, renal cell carcinoma, and pancreatic serous pseudopapillary tumor). In the remaining 3 patients, SDC was identified in wedge liver biopsies performed at the time of surgery, including gastric bypass surgery, cholecystectomy, and splenectomy. No other disease association was apparent in these cases. Conclusion. —Sinusoidal dilatation and congestion in liver biopsy is associated with venous outflow impairment in two thirds of the cases. In the absence of clinical and/or radiological evidence of venous outflow, diagnostic considerations include other vascular conditions, such as portal vein insufficiency and nodular regenerative hyperplasia. Sinusoidal dilatation and congestion can also occur in the setting of systemic inflammatory diseases, granulomatous disorders, and neoplasms, as well as in wedge biopsies obtained during abdominal surgery.
An Asymptomatic, Incidentally Discovered Pulmonary Tumor in a 41-Year-Old Woman
Carney, J. Aidan, Murali, Rajmohan

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 10, 2021 | Volume: 129 | Issue: 9 | Pages: e191-e194

10.5858/2005-129-e191-aaidpt | PMID 16120002 Get It

Pulmonary Crystal-Storing Histiocytoma
Pierson, Diane M., Qing, Gefei , Li, Maomi, Colby, Thomas V. , Leslie, Kevin O., Ionescu, Diana N.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 10, 2021 | Volume: 129 | Issue: 9 | Pages: 1159-1163

10.5858/2005-129-1159-pch | PMID 16119991 Get It

Abstract We describe the case of a 50-year-old woman with a lung tumor composed of crystal-storing histiocytes. These cells and associated plasma cells failed to show clonal light chain restriction, and the patient had no associated hematologic disorder. The differential diagnosis included crystal-storing histiocytosis, characterized by accumulation of crystallized immunoglobulins, a rare manifestation of monoclonal gammopathies/plasma cell dyscrasias. Crystal-laden histiocytes have previously been described in many organs. Four reports have described crystal-storing histiocytosis in the lung, always associated with a lymphoproliferative disorder. The present patient, 1 other case from our archive, and 1 case reported in the literature, all without an association with lymphoproliferative disorder, make a full description and definition of this lesion appropriate. The morphology, immunohistochemical profile, and electron microscopic features are described herein, and the term pulmonary crystal-storing histiocytoma is proposed. A practical algorithm is presented for the assessment of solitary lung masses composed of large histiocytic cells.
Cadherin 2-Related Arrhythmogenic Cardiomyopathy
Ghidoni, Alice , Elliott, Perry , Calkins, Hugh , James, Cynthia A. , Judge, Daniel P. , Murray, Brittney , Barc, Julien , Probst, Vincent , Schott, Jean‐Jacques , Song, Jiangping , Hauer, Richard N.W. , Hoorntje, Edgar T. , Tintelen, J. Peter van , Schulze‐Bahr, Eric , Hamilton, Robert M. , Mittal, Kirti, Semsarian, Christopher , Behr, Elijah R. , Ackerman, Michael J. , Basso, Cristina , Kotta, Maria‐Christina , Crotti, Lia , Crotti, Lia , Behr, Elijah Raphael , van Tintelen, J Peter , Kotta, Maria-Christina , Probst, Vincent , Barc, Julien , Jacques Schott, Jean , Hamilton, Robert , James, Cynthia A , Basso, Cristina , Syrris, Petros , Parati, Gianfranco , Gentilini, Davide , Mayosi, Bongani M. , Schwartz, Peter J. , Judge, Daniel P

Mayo Clinic

Circulation: Genomic and Precision Medicine | February 10, 2021 | Volume: 14 | Issue: 2 | Pages: No page available

10.1161/circgen.120.003097 | PMID 33566628 Get It

Background: Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiac disease characterized by fibrofatty replacement of the right and left ventricle, often causing ventricular dysfunction and life-threatening arrhythmias. Variants in desmosomal genes account for up to 60% of cases. Our objective was to establish the prevalence and clinical features of ACM stemming from pathogenic variants in the nondesmosomal cadherin 2 (CDH2), a novel genetic substrate of ACM. Methods: A cohort of 500 unrelated patients with a definite diagnosis of ACM and no disease-causing variants in the main ACM genes was assembled. Genetic screening of CDH2 was performed through next-generation or Sanger sequencing. Whenever possible, cascade screening was initiated in the families of CDH2 -positive probands, and clinical evaluation was performed. Results: Genetic screening of CDH2 led to the identification of 7 rare variants: 5, identified in 6 probands, were classified as pathogenic or likely pathogenic. The previously established p.D407N pathogenic variant was detected in 2 additional probands. Probands and family members with pathogenic/likely pathogenic variants in CDH2 were clinically evaluated, and along with previously published cases, altogether contributed to the identification of gene-specific features (13 cases from this cohort and 11 previously published, for a total of 9 probands and 15 family members). Ventricular arrhythmic events occurred in most CDH2 -positive subjects (20/24, 83%), while the occurrence of heart failure was rare (2/24, 8.3%). Among probands, sustained ventricular tachycardia and sudden cardiac death occurred in 5/9 (56%). Conclusions: In this worldwide cohort of previously genotype-negative ACM patients, the prevalence of probands with CDH2 pathogenic/likely pathogenic variants was 1.2% (6/500). Our data show that this cohort of CDH2 -ACM patients has a high incidence of ventricular arrhythmias, while evolution toward heart failure is rare.
Internal Jugular Vein Thrombus in Coronavirus Disease (COVID-19)
Koritala, Thoyaja , Johnson, David W.

Mayo Clinic

American Journal of Roentgenology | February 10, 2021 | Volume: 217 | Issue: 1 | Pages: 257-257

10.2214/ajr.21.25559 | PMID 33566679 Get It